Filing Flows › Aytu Biopharma (AYTU) › Free cash flow
Aytu Biopharma (AYTU) free cash flow by quarter
Aytu Biopharma's free cash flow was $4.4M in Q4 FY26 (fourth quarter fiscal 2026), +20% from Q2 FY26. Over the last 4 quarters it ranged from $2.8M (Q4 FY25) to $4.4M (Q4 FY26).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q4 FY26 | $4.4M | +20% | +58% |
| Q2 FY26 | $3.7M | +31% | +26% |
| Q4 FY25 | $2.8M | -4% | — |
| Q2 FY25 | $2.9M | — | — |
Q4 FY26 at a glance
Aytu Biopharma, Q4 FY26: revenue $16.1M (+6% year over year), operating margin -4.8%, net loss $15K, operating cash flow $4.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Aytu Biopharma's free cash flow?
Aytu Biopharma's free cash flow was $4.4M in Q4 FY26 (fourth quarter fiscal 2026), +20% from Q2 FY26.
How has Aytu Biopharma's free cash flow changed?
Over the last 4 quarters it ranged from $2.8M (Q4 FY25) to $4.4M (Q4 FY26).